{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:52:54Z","timestamp":1784173974016,"version":"3.55.0"},"reference-count":56,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Childhood Obesity"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Individuals with Duchenne muscular dystrophy (DMD) have increased risk of obesity from prolonged glucocorticoid use and progressive muscle weakness. Over 50% have obesity by the teenage years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The current study examines literature on obesity management in DMD and describes how obesity pharmacotherapy can be used in this high-risk cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review was conducted in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. A Pubmed Database search was conducted from January 2000 to May 2024. Included terms were DMD and topiramate, phentermine, metformin, glucagon-like peptide-1 receptor agonist, semaglutide, and liraglutide. Eligible studies were cataloged to examine obesity pharmacotherapy, side effect profiles, and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty studies met inclusion criteria, 18 on metformin. Reviewed studies varied in duration from 4 to 24 weeks, ages 6.5\u201344 years old, with 112 participants total (range: 1\u201330 participants). Included studies were: eight animal studies, six clinical trials, four reviews, one cohort study, and one case report. Primary outcomes varied among studies: muscular degeneration and function (15 articles), cardiac function (2 articles), weight loss (2 articles), and general endocrine care (1 article).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Adjunct obesity pharmacotherapy use in youth with DMD is promising but needs to be confirmed. Large gaps include appropriate agent selection, side effect monitoring, and dose escalation. The overall quality of pediatric-specific evidence for the use of obesity pharmacotherapy in youth with DMD is low. Future research is needed to investigate how to safely utilize these agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/chi.2024.0297","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T05:16:58Z","timestamp":1728623818000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Obesity Management in Youth with Duchenne Muscular Dystrophy: A Review of Metformin and Alternative Pharmacotherapies"],"prefix":"10.1177","volume":"21","author":[{"given":"Victoria","family":"Goldman","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ryabets-Lienhard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Kohli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Sousa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Marpuri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-6255","authenticated-orcid":false,"given":"Alaina P.","family":"Vidmar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"16","key":"e_1_3_6_2_2","doi-asserted-by":"crossref","DOI":"10.3390\/nu14163304","article-title":"The relationship between obesity and clinical outcomes in young people with duchenne muscular dystrophy","volume":"14","author":"Billich N","year":"2022","unstructured":"Billich N, , Adams J, , Carroll K, et al. The relationship between obesity and clinical outcomes in young people with duchenne muscular dystrophy. Nutrients, 2022; 14(16).","journal-title":"Nutrients"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00248-3"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90579-4"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2009.00979.x"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32910-1"},{"issue":"11","key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pd.1031","article-title":"Prenatal diagnosis of DMD in a female foetus affected by Turner syndrome","volume":"24","author":"Satre V","year":"2004","unstructured":"Satre V, , Monnier N, , Devillard F, et al. Prenatal diagnosis of DMD in a female foetus affected by Turner syndrome. Prenat Diagn, 2004; 24(11):913\u2013917.","journal-title":"Prenat Diagn"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.03.011"},{"issue":"2","key":"e_1_3_6_9_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1542\/peds.2018-0333F","article-title":"Obesity and endocrine management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Weber DR","year":"2018","unstructured":"Weber DR, , Hadjiyannakis S, , McMillan HJ, et al. Obesity and endocrine management of the patient with Duchenne muscular dystrophy. Pediatrics, 2018; 142(Suppl 2):S43\u2013S52.","journal-title":"Pediatrics"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114510005180"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/cch.13054"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.08.006"},{"issue":"1","key":"e_1_3_6_13_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1203\/00006450-199607000-00006","article-title":"Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy","volume":"40","author":"Hankard R","year":"1996","unstructured":"Hankard R, , Gottrand F, , Turck D, et al. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res, 1996; 40(1):29\u201333.","journal-title":"Pediatr Res"},{"issue":"19","key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"021037","DOI":"10.1161\/JAHA.121.021037","article-title":"The effect of adiposity on cardiovascular function and myocardial fibrosis in patients with Duchenne muscular dystrophy","volume":"10","author":"Henson SE","year":"2021","unstructured":"Henson SE, , Lang SM, , Khoury PR, et al. The effect of adiposity on cardiovascular function and myocardial fibrosis in patients with Duchenne muscular dystrophy. J Am Heart Assoc, 2021; 10(19):e021037.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"e_1_3_6_15_2","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.21037\/qims.2020.02.06","article-title":"MRI in the assessment of adipose tissues and muscle composition: How to use it","volume":"10","author":"Huber FA","year":"2020","unstructured":"Huber FA, , Del Grande F, , Rizzo S, et al. MRI in the assessment of adipose tissues and muscle composition: How to use it. Quant Imaging Med Surg, 2020; 10(8):1636\u20131649.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"e_1_3_6_16_2","doi-asserted-by":"crossref","first-page":"18762","DOI":"10.1038\/s41598-022-23072-5","article-title":"Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy","volume":"12","author":"Sherlock SP","year":"2022","unstructured":"Sherlock SP, , Palmer J, , Wagner KR, et al. Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophy. Sci Rep, 2022; 12(1):18762.","journal-title":"Sci Rep"},{"key":"e_1_3_6_17_2","doi-asserted-by":"crossref","first-page":"867273","DOI":"10.1155\/2015\/867273","article-title":"Evidence of insulin resistance and other metabolic alterations in boys with Duchenne or Becker muscular dystrophy","volume":"2015","author":"Rodr\u00edguez-Cruz M","year":"2015","unstructured":"Rodr\u00edguez-Cruz M, , Sanchez R, , Escobar RE, et al. Evidence of insulin resistance and other metabolic alterations in boys with Duchenne or Becker muscular dystrophy. Int J Endocrinol, 2015; 2015:867273.","journal-title":"Int J Endocrinol"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2015.09.004"},{"issue":"21","key":"e_1_3_6_19_2","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1080\/09638288.2020.1725155","article-title":"Growth assessment and weight management in paediatric neuromuscular clinics: A cross-sectional survey across Canada","volume":"43","author":"McPherson AC","year":"2021","unstructured":"McPherson AC, , Amin R, , McAdam L, et al. Growth assessment and weight management in paediatric neuromuscular clinics: A cross-sectional survey across Canada. Disabil Rehabil, 2021; 43(21):3015\u20133020.","journal-title":"Disabil Rehabil"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.12.006"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.06.599"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-150071"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951122001342"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2021.2008528"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15404"},{"issue":"3","key":"e_1_3_6_26_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mus.26340","article-title":"Body composition and body mass index in Duchenne muscular dystrophy: Role of dietary intake","volume":"59","author":"Bernabe-Garc\u00eda M","year":"2019","unstructured":"Bernabe-Garc\u00eda M, , Rodr\u00edguez-Cruz M, , Atilano S, et al. Body composition and body mass index in Duchenne muscular dystrophy: Role of dietary intake. Muscle Nerve, 2019; 59(3):295\u2013302.","journal-title":"Muscle Nerve"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12987"},{"issue":"6","key":"e_1_3_6_28_2","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060594","article-title":"Nutritional challenges in Duchenne muscular dystrophy","volume":"9","author":"Salera S","year":"2017","unstructured":"Salera S, , Menni F, , Moggio M, et al. Nutritional challenges in Duchenne muscular dystrophy. Nutrients, 2017; 9(6).","journal-title":"Nutrients"},{"issue":"2","key":"e_1_3_6_29_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.2018-0333G","article-title":"Nutritional and gastrointestinal management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Brumbaugh D","year":"2018","unstructured":"Brumbaugh D, , Watne L, , Gottrand F, et al. Nutritional and gastrointestinal management of the patient with Duchenne muscular dystrophy. Pediatrics, 2018; 142(Suppl 2):S53\u2013S61.","journal-title":"Pediatrics"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30024-3"},{"issue":"2","key":"e_1_3_6_31_2","article-title":"Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity","volume":"151","author":"Hampl SE","year":"2023","unstructured":"Hampl SE, , Hassink SG, , Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 2023; 151(2).","journal-title":"Pediatrics"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-1176"},{"issue":"9","key":"e_1_3_6_33_2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.23207","article-title":"Metformin for pediatric obesity and insulin resistance: A retrospective study within an integrated health care system","volume":"29","author":"Concepcion JQ","year":"2021","unstructured":"Concepcion JQ, , Tucker LY, , Huang K. Metformin for pediatric obesity and insulin resistance: A retrospective study within an integrated health care system. Obesity (Silver Spring), 2021; 29(9):1526\u20131537.","journal-title":"Obesity (Silver Spring)"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2022-0252"},{"issue":"01","key":"e_1_3_6_35_2","first-page":"PS02","article-title":"Improved muscle function in Duchenne muscular dystrophy using a combination of L-Arginine and Metformin","volume":"46","author":"Bonati U","year":"2015","unstructured":"Bonati U, , Hafner P, , Erne B, et al. Improved muscle function in Duchenne muscular dystrophy using a combination of L-Arginine and Metformin. Neuropediatrics, 2015; 46(S 01):PS02\u2013P34.","journal-title":"Neuropediatrics"},{"issue":"1","key":"e_1_3_6_36_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13063-016-1503-1","article-title":"Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: Study protocol for a single-centre, randomised, placebo-controlled trial","volume":"17","author":"Hafner P","year":"2016","unstructured":"Hafner P, , Bonati U, , Rubino D, et al. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: Study protocol for a single-centre, randomised, placebo-controlled trial. Trials, 2016; 17(1):389.","journal-title":"Trials"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.642908"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2014.11.202"},{"issue":"6","key":"e_1_3_6_39_2","first-page":"719","article-title":"Transaminitis in Duchenne\u2019s muscular dystrophy","volume":"29","author":"Tay SK","year":"2000","unstructured":"Tay SK, , Ong HT, , Low PS. Transaminitis in Duchenne\u2019s muscular dystrophy. Ann Acad Med Singap, 2000; 29(6):719\u2013722.","journal-title":"Ann Acad Med Singap"},{"issue":"10","key":"e_1_3_6_40_2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00467-020-04587-3","article-title":"Kidney involvement and associated risk factors in children with Duchenne muscular dystrophy","volume":"35","author":"Kutluk MG","year":"2020","unstructured":"Kutluk MG, , Do\u011fan \u00c7S. Kidney involvement and associated risk factors in children with Duchenne muscular dystrophy. Pediatr Nephrol, 2020; 35(10):1953\u20131958.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"e_1_3_6_41_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1399-5448.2009.00512.x","article-title":"Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit","volume":"11","author":"Casteels K","year":"2010","unstructured":"Casteels K, , Fieuws S, , van Helvoirt M, et al. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes, 2010; 11(1):61\u201369.","journal-title":"Pediatr Diabetes"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00979-0"},{"key":"e_1_3_6_43_2","doi-asserted-by":"crossref","first-page":"609493","DOI":"10.3389\/fcell.2020.609493","article-title":"Metformin reverses the enhanced myocardial sr\/er-mitochondria interaction and impaired complex i-driven respiration in dystrophin-deficient mice","volume":"8","author":"Angebault C","year":"2020","unstructured":"Angebault C, , Panel M, , Lac\u00f4te M, et al. Metformin reverses the enhanced myocardial sr\/er-mitochondria interaction and impaired complex i-driven respiration in dystrophin-deficient mice. Front Cell Dev Biol, 2020; 8:609493.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"e_1_3_6_44_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40272-022-00532-z","article-title":"Phentermine\/Topiramate: Pediatric first approval","volume":"24","author":"Dhillon S","year":"2022","unstructured":"Dhillon S. Phentermine\/Topiramate: Pediatric first approval. Paediatr Drugs, 2022; 24(6):715\u2013720.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"e_1_3_6_45_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1467-789X.2010.00846.x","article-title":"Efficacy and safety of topiramate on weight loss: A meta-analysis of randomized controlled trials","volume":"12","author":"Kramer CK","year":"2011","unstructured":"Kramer CK, , Leit\u00e3o CB, , Pinto LC, et al. Efficacy and safety of topiramate on weight loss: A meta-analysis of randomized controlled trials. Obes Rev, 2011; 12(5):e338\u2013e347.","journal-title":"Obes Rev"},{"issue":"6","key":"e_1_3_6_46_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mus.20321","article-title":"Topiramate for weight reduction in Duchenne muscular dystrophy","volume":"31","author":"Carter GT","year":"2005","unstructured":"Carter GT, , Yudkowsky MP, , Han JJ, et al. Topiramate for weight reduction in Duchenne muscular dystrophy. Muscle Nerve, 2005; 31(6):788\u2013789.","journal-title":"Muscle Nerve"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.7602"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1437143"},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23619"},{"key":"e_1_3_6_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221108064"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12434"},{"key":"e_1_3_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60205-5"},{"key":"e_1_3_6_53_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.024927"},{"key":"e_1_3_6_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.330"},{"key":"e_1_3_6_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1831"},{"key":"e_1_3_6_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208601"},{"key":"e_1_3_6_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3224"}],"container-title":["Childhood Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/chi.2024.0297","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/chi.2024.0297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/chi.2024.0297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:25:07Z","timestamp":1777386307000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/chi.2024.0297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,1]]}},"alternative-id":["10.1089\/chi.2024.0297"],"URL":"https:\/\/doi.org\/10.1089\/chi.2024.0297","relation":{},"ISSN":["2153-2168","2153-2176"],"issn-type":[{"value":"2153-2168","type":"print"},{"value":"2153-2176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}